Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

1.

Landmarks in prostate cancer screening.

Schröder FH.

BJU Int. 2012 Oct;110 Suppl 1:3-7. doi: 10.1111/j.1464-410X.2012.011428.x. Review.

PMID:
23046034
[PubMed - indexed for MEDLINE]
2.

Screening for prostate cancer: the current evidence and guidelines controversy.

Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.

Can J Urol. 2011 Oct;18(5):5875-83. Review.

PMID:
22018148
[PubMed - indexed for MEDLINE]
Free Article
3.

Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme.

Boniol M, Boyle P, Autier P, Ruffion A, Perrin P.

BJU Int. 2012 Dec;110(11):1648-52. doi: 10.1111/j.1464-410X.2012.11513.x. Epub 2012 Sep 18.

PMID:
22984785
[PubMed - indexed for MEDLINE]
4.

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH; European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group.

Int J Cancer. 2002 Jan 10;97(2):237-44.

PMID:
11774270
[PubMed - indexed for MEDLINE]
5.

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.

Hayes JH, Barry MJ.

JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085. Review.

PMID:
24643604
[PubMed - indexed for MEDLINE]
6.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
[PubMed - indexed for MEDLINE]
7.

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

Wever EM, Draisma G, Heijnsdijk EA, Roobol MJ, Boer R, Otto SJ, de Koning HJ.

J Natl Cancer Inst. 2010 Mar 3;102(5):352-5. doi: 10.1093/jnci/djp533. Epub 2010 Feb 8.

PMID:
20142584
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Screening for prostate cancer: an up date].

Ito K.

Gan To Kagaku Ryoho. 2012 Jan;39(1):33-7. Japanese.

PMID:
22241351
[PubMed - indexed for MEDLINE]
9.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.

PMID:
22228146
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Estimating standard performance measures of opportunistic screening for prostate cancer].

Leoni M, Falcini F, Ravaioli A, Foca F, Andalò G, Benini F, Dal Pozzo C, Ricci R, Naldoni C, Bucchi L.

Epidemiol Prev. 2008 Nov-Dec;32(6):285-93. Italian.

PMID:
19353962
[PubMed - indexed for MEDLINE]
11.

Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Bokhorst LP, Bangma CH, van Leenders GJ, Lous JJ, Moss SM, Schröder FH, Roobol MJ.

Eur Urol. 2014 Feb;65(2):329-36. doi: 10.1016/j.eururo.2013.08.005. Epub 2013 Aug 11.

PMID:
23954085
[PubMed - indexed for MEDLINE]
12.

Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Luján M, Páez A, Pascual C, Angulo J, Miravalles E, Berenguer A.

Eur Urol. 2006 Dec;50(6):1234-40; discussion 1239-40. Epub 2006 May 3.

PMID:
16704893
[PubMed - indexed for MEDLINE]
13.

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].

Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.

Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28. French.

PMID:
19559380
[PubMed - indexed for MEDLINE]
14.

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.

Eur Urol. 2011 Aug;60(2):330-6. doi: 10.1016/j.eururo.2011.05.013. Epub 2011 May 17.

PMID:
21601352
[PubMed - indexed for MEDLINE]
15.

[Clinical value of prostate specific antigen screening in early detection of prostate cancer].

Hua LX, Qiao D, Song NH, Feng NH, Yang J, Zhang JX, Chen JG, Zhang W, Sui YG, Wu HF.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):705-9. Chinese.

PMID:
20021870
[PubMed - indexed for MEDLINE]
16.

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.

Prostate. 2000 Sep 15;45(1):19-35.

PMID:
10960839
[PubMed - indexed for MEDLINE]
17.

Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts.

Rove KO, Crawford ED.

World J Urol. 2012 Apr;30(2):137-42. doi: 10.1007/s00345-011-0799-4. Epub 2011 Nov 25. Review.

PMID:
22116599
[PubMed - indexed for MEDLINE]
18.

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland.

Kwiatkowski M, Huber A, Stamm B, Lehmann K, Wernli M, Häfeli A, Recker F.

BJU Int. 2003 Dec;92 Suppl 2:44-7.

PMID:
14983954
[PubMed - indexed for MEDLINE]
19.

Prostate cancer mortality in the Finnish randomized screening trial.

Kilpeläinen TP, Tammela TL, Malila N, Hakama M, Santti H, Määttänen L, Stenman UH, Kujala P, Auvinen A.

J Natl Cancer Inst. 2013 May 15;105(10):719-25. doi: 10.1093/jnci/djt038. Epub 2013 Mar 11.

PMID:
23479454
[PubMed - indexed for MEDLINE]
Free Article
20.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

PMID:
23924423
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk